Navigation Links
Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure

YORK, England, July 30, 2015 /PRNewswire/ --

Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, announces that it has further strengthened its position within the post-acute wound care market as Tissue Regenix Wound Care Inc. has received further approval for DermaPure® under Medicare administrator, First Coast Service Options Inc. ("First Coast") whose jurisdiction includes Florida, Puerto Rico and the US Virgin Islands.


With this approval, Tissue Regenix Wound Care Inc. increases the number of Medicare beneficiaries to whom DermaPure® is available by 2.5m. With prior approvals from Noridian Health Care Solutions, Palmetto GBA, Novitas Solutions and CGS Administrators within the first seven months of market availability, DermaPure® is now available across 31 States, the US Virgin Islands and Puerto Rico and is accessible to c.65% of the 37m beneficiaries enrolled under the Medicare programme.

The Medicare programme within the United States acts a national insurance programme available to citizens of 65 and over, subsidising healthcare costs and providing access to treatment that may otherwise not be available. This approval by First Coast means that medical establishments under their jurisdiction can now seek reimbursement for the use of DermaPure® in outpatient scenarios.

Antony Odell, CEO of Tissue Regenix Group plc:

"Tissue Regenix continues to make significant progress in securing these critical approvals, not only allowing more patients to benefit from improved clinical outcomes, but  demonstrating both the efficacy of the product and the strength of our hybrid commercialisation strategy.

"Commercial interest in DermaPure® continues to grow and I look forward to announcing further LCD coverage approvals and expanding commercial payer coverage in due course."


Previously announced DermaPure® coverage approvals:

Novitas Solutions: Arkansas, Colorado, Delaware, Louisiana, Maryland, Mississippi, New Jersey, New Mexico, Oklahoma, Pennsylvania, Texas and  Washington DC

CGS:  Kentucky and Ohio

Noridian Healthcare Solutions: Alaska, Arizona, California, Hawaii, Montana, Nevada, North Dakota, Oregon, South Dakota, Utah, Washington and Wyoming.

Palmetto GBA: North Carolina, South Carolina, Virginia and West Virginia

For Further Information 

About Tissue Regenix 

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human tissue leaving an acellular tissue scaffold which is not rejected by the patient's body which can then be used to repair diseased or worn out body parts. The potential applications of this process are diverse and address many critical clinical needs such as vascular disease, heart valve replacement and knee repair.

Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds. The company commercialises academic research conducted by our partners around the World. In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States- 'Tissue Regenix Wound Care Inc.', as part of its commercialisation strategy for its dCELL® technology platform.

Tissue Regenix Group Plc:
Caitlin Pearson
Corporate Communications Officer

Jefferies International Ltd:
Simon Hardy
Harry Nicholas

Tulchan Communications:
Tom Buchanan
Victoria Huxster    
Matt Low

SOURCE Tissue Regenix Group Plc
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
2. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
3. Oncos Therapeutics Granted Orphan Drug Designation for CGTG-102 in Soft Tissue Sarcoma (STS) by FDA and EMA
4. 2013 Ending The Wait Awards Honor Five Premier Colorado Hospitals For Organ And Tissue Donation Achievements
5. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
6. Brazilian Market for Orthopedic Soft Tissue Repair & Sports Medicine
7. Frost & Sullivan Unveils Future Opportunities for the Tissue Diagnostics Market
8. Jeeven BioSciences, Inc. Announces the Release of its Neuro-X(TM) Serum Free and Xeno Free Tissue Culture Media
9. AB103 Granted Orphan Medicinal Product Designation in the European Union for the Treatment of Necrotizing Soft Tissue Infections (NSTI)
10. Tissue and Hygiene in the United Kingdom
11. Orthopedic Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Post Your Comments:
(Date:8/19/2019)... ... August 19, 2019 , ... The International Association of Eating ... within the field of treatment for eating disorders, recommends membership for professionals who ... have a similar mission. , Founded in 1985, the iaedp™ Foundation is ...
(Date:8/16/2019)... ... August 16, 2019 , ... SignatureCare Emergency Center ... of Houston, TX including Montrose, Heights, Memorial City, and Bellaire, TX. , The ... Houston Heights, is aimed at helping Houston families get their children caught up ...
(Date:8/16/2019)... ... August 16, 2019 , ... Today, Point-of-Care Partners announced Government ... has joined the company as a Government Affairs and Health IT Strategist. In ... standards organizations to advance use of health IT for comprehensive medication management. , ...
Breaking Medicine Technology:
(Date:8/16/2019)... PARK, N.Y. (PRWEB) , ... August 16, 2019 ... ... fabricated, and donated a custom handcrafted, one-of-a-kind children’s aircraft to Ronald McDonald House ... was designed to give children residents undergoing medical treatments and their family members ...
(Date:8/16/2019)... ... 2019 , ... Dr. Demetri Arnaoutakis, a board-certified hair restoration ... , The Haute Beauty Network, well known for its exclusive and luxurious lifestyle ... expert and our newest addition to the Haute Beauty members-only network. , Haute ...
(Date:8/15/2019)... ... August 15, 2019 , ... The ASCP Foundation has ... directly affected by the closure of Hahnemann University Hospital in Philadelphia, which is ... the ASCP Foundation will be making hardship grants of up to $2,500 per ...
(Date:8/15/2019)... ... August 15, 2019 , ... Jon O'Brien, ... for family planning clinics to provide written assurance that they will comply with ... to the Global Gag Rule, the new policy restricts providers and clinics that ...
(Date:8/14/2019)... , ... August 14, 2019 , ... Teguar Corporation has ... in America. This list has long-been established as a mark of success for some ... Dell, and Oracle. Teguar made the list in 2015, 2016 and 2017. This year, ...
Breaking Medicine News(10 mins):